Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation

Custom Monoclonal Antibodies

75D30124Q78028

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Awarded

Genscript USA Inc.

$0.00 obligated so far on USAspending

Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities

This one was awarded in 2024

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

GenScript Custom Monoclonal Antibodies This contract action is for supplies that the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. CEMB utilizes GenScript Custom Monoclonal Antibodies within our laboratory. The supply of Custom Monoclonal antibodies is paramount to our lab work.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. The NAICS 541714 and the PSC AJ13 are the classifications for this biological procurement. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.

Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Gary Morgan, Contract Specialist at gmorgan1@cdc.gov by 5:00PM EST Monday, July 29, 2024.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Genscript USA Inc.
UEI
KVLBRRAQ6UX1
CAGE
5THB5
Vendor location
Piscataway, NJ
Contract
75D30124P19829, purchase order
Obligated
$0.00
Actions
3 between September 5, 2024 and September 30, 2025
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Custom Monoclonal Antibodies
Match
solicitation number 75D30124Q78028 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 22, 2024

    Combined synopsis and solicitation

    Due July 29, 2024 at 5:00 PM EDT. SAM.gov, notice 7c44cf9d0dfd4804bf9d420fbc335c89

Points of contact